Lilly’s combo therapy succeeds in late-stage lung cancer study

42

Eli Lilly and Co’s combination cancer treatment met the main goal of a late-stage clinical trial testing it on patients with a form of lung cancer, the drugmaker announced on Tuesday.

http://feeds.reuters.com/~r/reuters/healthNews/~3/WWTjBhkX4Rg/lillys-combo-therapy-succeeds-in-late-stage-lung-cancer-study-idUSKBN1QT1BN